Click to Share
 

CNS-disease Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

By STATegics, Inc.
STATegics, Inc. announced today that The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has awarded the company a second grant to advance its proprietary agonists of the tissue-protective erythropoietin receptor for the treatment of...
By STATegics, Inc.
The Michael J. Fox Foundation Awards Grant to Support STATegics’ Preclinical Studies of Small Molecule Erythropoietin Receptor Agonists for the Treatment of Parkinson’s Disease
By STATegics, Inc.
STATegics, Inc. awarded a new grant from the Friedreich’s Ataxia Research Alliance (FARA) to advance erythropoietin receptor agonist compounds for the treatment of Friedreich’s ataxia (FRDA).

Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share